# Glucose Variability With DPP-4 Inhibition

> **NCT01751321** · NA · UNKNOWN · sponsor: **Research Clinical Centre of the Russian Railways, JSC** · enrollment: 50 (estimated)

## Conditions studied

- Type 2 Diabetes

## Interventions

- **DRUG:** Sitagliptin, placebo

## Key facts

- **NCT ID:** NCT01751321
- **Lead sponsor:** Research Clinical Centre of the Russian Railways, JSC
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-05
- **Primary completion:** 2013-09
- **Final completion:** 2013-10
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2012-12-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01751321

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01751321, "Glucose Variability With DPP-4 Inhibition". Retrieved via AI Analytics 2026-07-10 from https://api.ai-analytics.org/clinical/NCT01751321. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*